Navigation Links
Beaumont Hospital Launches Study of Single-Dose Radiation Treatment for Prostate Cancer
Date:12/16/2010

ROYAL OAK, Mich., Dec. 16, 2010 /PRNewswire/ -- Beaumont Hospital radiation oncologists have launched a research study to treat men with low to intermediate risk prostate cancer with a single dose of radiation.

Alvaro Martinez, M.D., FACR, professor and chair, Oakland University William Beaumont School of Medicine, department of Radiation Oncology, Beaumont Hospitals, performed the first-in-the-world one-dose, High-Dose Rate brachytherapy procedure Nov. 29 on a man from Beverly Hills, Mich.

The study, approved by Beaumont's Human Investigation Committee, builds upon 18 years of past research by Dr. Martinez and other Beaumont radiation oncologists on ways to kill cancer cells through powerful, targeted, short-term radiation treatment.

"In the future of cancer care, less is more," says Dr. Martinez. "Patients want treatments that are safe, effective and fast with a high chance of a cure, thus allowing them to move on with their lives as soon as possible. Through our research, we are hoping to develop treatments that achieve these goals for patients."

HDR brachytherapy involves the temporary implantation of a "smart seed" – an Iridium 192 radioactive pellet about the size of grain of rice – at the prostate tumor site. This technique delivers more radiation to the prostate, increasing cancer killing probability, while minimizing radiation exposure to surrounding tissues, such as the bladder, urethra and rectum. Unlike permanent radioactive seed implants, no radioactive material is left in the patient's body, eliminating the risk of radiation exposure for partners or family members.

The entire procedure to temporarily implant the seed takes about three hours, once spinal anesthesia has been administered. Plastic needles are placed into the prostate using ultrasound guidance. The needles are then loaded with a single radiation seed through a cable attached to a computerized machine that moves the "smart seed" at precisely timed intervals along the needles. Treatment with the "smart seeds" takes about 15 minutes.

Low and intermediate risk patients who qualify for study participation include those with T1c through T2b tumors (small size with no metastasis or lymph node involvement), a Gleason score of 6 or 7 (low-intermediate cell aggressiveness) and a prostate-specific antigen score lower than 15.

For more information on the study or a consultation, call 248-551-7058 (for Beaumont Hospital, Royal Oak) or 248-964-3070 (for Beaumont Hospital, Troy).

Current methods for treating prostate cancer confined to the prostate gland include surgical removal of the prostate (radical prostatectomy); up to eight weeks of external beam radiation alone or combined with permanent seed implants or HDR brachytherapy; or permanent seed implants and/or HDR brachytherapy. The methods are about equal in effectiveness with different side effects.

In 1992, Dr. Martinez and his Beaumont colleagues were the first in the U.S. to perform HDR brachytherapy as an outpatient treatment for patients with locally-advanced prostate cancer. In 1995, he developed a four-treatment protocol over two days for patients with low to intermediate risk prostate cancer. A total of 1,045 patients with high, intermediate or low-risk prostate cancer have been treated through HDR brachytherapy research at Beaumont since 1992.

Beaumont's comprehensive cancer program combines the expertise of Beaumont Hospitals with the knowledge and experience of physicians in the Beaumont Oncology Network, the largest group of oncology specialists in the state, to offer cancer prevention counseling, diagnosis and treatment in hospital and community-based settings. The Beaumont Cancer Institute is one of only 47 Community Clinical Oncology Programs in the country designated by the National Cancer Institute to provide patients with access to leading-edge cancer clinical research trials.

HIC study 2006-038

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Alvaro Martinez, M.D.   |   https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=43100


'/>"/>
SOURCE William Beaumont Hospital
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Beaumont Hospital Opens New Ernst Cardiovascular Center
2. Beaumont Patients 1st to get Next Generation of Radiation Treatment
3. TeleTracking Presents Conference on RTLS Hospital Asset Tracking
4. Milliman Care Guidelines® Now Used in More Than 1,000 Hospitals
5. Med Time Technology, Inc. Teams up with Give A Smile, Inc. to Provide Pill Timer™ Kits and Toys to Children and Parents at the Chris Evert Childrens Hospital of Broward General
6. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
7. Reportlinker Adds Europe Hospital Supplies Market Outlook to 2016
8. CareFusion Launches Respiratory Airway Adapter to Improve Patient Safety and Reduce Hospital Costs
9. CareFusion to Provide Pyxis® Point-of-Care Products to Veterans Affairs Hospitals Nationwide
10. ECRI Institute PSO Chosen by Tennessee Hospital Association for Patient Safety Services
11. Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... Market Research titled "Global Market Study on Automated Endoscope Reprocessors: ... Register a CAGR of 8.6% Between 2016 and 2024 " the ... 2015 and is expected to expand at a CAGR of ... market valuation of US$ 1,367.6 Mn by 2024. ...
(Date:12/2/2016)... Dec. 2, 2016 In the first ever ... from those derived from C. sativa, the Hebrew University ... di Napoli Federico II , the Universita` del Piemonte ... comprehensive, critical, integrated and unified inventory of phytocannabinoids of ... focuses on the remarkable chemical and structural diversity of ...
(Date:12/2/2016)... RICHMOND, British Columbia , December 2, 2016 ... Produkt, den INSTI HIV-Selbsttest, bei den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
Breaking Medicine Technology:
(Date:12/2/2016)... , ... December 02, 2016 , ... U.S. Surgeon General, ... with Mediaplanet, Dr. Murthy explains how he was inspired to practice medicine at an ... that medicine is about more than making diagnoses and prescribing medicine,” he states. “It ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. ... will be included in the 2016 “Guide to America’s Top Plastic Surgeons” for ... the amalgamation of their education, experience, and professional associations. , One the ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, ... entry through labeling, storing, shipping and disposal. The new version is a faster ...
(Date:12/2/2016)... Milford, NJ (PRWEB) , ... December 02, 2016 , ... ... Nothing Water has some unique properties including its unmatched natural purity of just 6 ... as clean and crisp. , Nothing Water has been available in several ShopRite and ...
(Date:12/2/2016)... ... December 02, 2016 , ... "Pro3rd Accents Volume 2 is ... create versatile lower third titles with just a few clicks of the mouse," said ... includes 30 lower third animations. Choose from various styles with accented animations, rigid boxes, ...
Breaking Medicine News(10 mins):